From Medscape Rheumatology

Coverage from the

Pediatric Rheumatology Symposium (PRSYM) 2023

March 29 - April 01, 2023; New Orleans, Louisiana

March 29 - April 01, 2023 New Orleans, Louisiana

PRSYM 2023 Answers Sought for Mental Health Needs in Pediatric Rheumatology One study found a tremendous increase in screening by automating the process while another found remote delivery of a 6-week cognitive behavioral program to improve mood and pain symptoms.
Medscape Medical News, April 13, 2023
PRSYM 2023 Rheumatic, MIS-C Patients' Parents Strongly Hesitant of COVID Vax A single-center study and a survey of rheumatologists revealed similar levels of hesitancy among parents of both these populations.
Medscape Medical News, April 11, 2023
PRSYM 2023 Pre-Transfer Rheumatologist Visits Smooth Adolescent Transition The time from the last pediatric visit to the first adult visit was substantially shorter for patients who had a dual provider pre-transfer visit.
Medscape Medical News, April 4, 2023

Conference News

PRSYM 2023 Answers Sought for Mental Health Needs in Pediatric Rheumatology
Medscape Medical News, April 13, 2023
PRSYM 2023 Rheumatic, MIS-C Patients' Parents Strongly Hesitant of COVID Vax
Medscape Medical News, April 11, 2023
PRSYM 2023 Pre-Transfer Rheumatologist Visits Smooth Adolescent Transition
Medscape Medical News, April 4, 2023

PRSYM 2023 Rheumatology Faculty in Pediatric Programs Unchanged Since 2004
Medscape Medical News, April 3, 2023
PRSYM 2023 Childhood Lupus Severity Linked to Social Determinants of Health
Medscape Medical News, April 3, 2023

Medscape Rheumatology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News in Rheumatology

VEXAS Syndrome: More Common and Severe Than Expected A large US analysis found that this newly discovered genetic disease has an estimated prevalence of 1 in 4269 in men older than 50.
Medscape Medical News, Jan 25, 2023
Best Estimates Made for Hydroxychloroquine Retinopathy Risk Hydroxychloroquine dosing and retinopathy risk have long been a concern with its use. A new, comprehensive study finds that retinopathy diagnosis with cumulative dosing is actually low.
Medscape Medical News, Jan 17, 2023
Health Plans Get Very Poor Scores for Access to Autoimmune Drugs Three out of four insurance plans use policies that result in significant to severe restriction of access to medications for seven autoimmune diseases, according to the analysis.
Medscape Medical News, Feb 14, 2023

Related Coverage

Related Resources